{"id":153409,"title":"Use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines: NACI public health level recommendations. - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T12:20:22.663000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/public-health-level-recommendations-use-pneumococcal-vaccines-adults-including-use-15-valent-20-valent-conjugate-vaccines.html","snippet":"Use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines: NACI public health level recommendations. - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search…","rawSnapshotUrl":"/api/snapshots/raw/153409","browseUrl":"https://replay.healtharchive.ca/job-1/20250418122022/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/public-health-level-recommendations-use-pneumococcal-vaccines-adults-including-use-15-valent-20-valent-conjugate-vaccines.html#ha_snapshot=153409","mimeType":"text/html","statusCode":200}